Brevan Howard Capital Management LP Surmodics Inc Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Surmodics Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 9,511 shares of SRDX stock, worth $273,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,511
Previous 5,522
72.24%
Holding current value
$273,155
Previous $218,000
33.03%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRDX
# of Institutions
140Shares Held
12.1MCall Options Held
31.3KPut Options Held
17.9K-
Black Rock Inc. New York, NY1.17MShares$33.6 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY849KShares$24.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$22.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$22.7 Million1.99% of portfolio
-
Morgan Stanley New York, NY676KShares$19.4 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $402M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...